Similar mechanisms have been postulated to cause acute respiratory distress syndrome (ARDS) in COVID-19,11,12 but systemic ACE2 increases markedly in COVID-19 patients with severe disease progression.13 This evidence concerns the gene ACE2 and acute respiratory distress syndrome.